References
- Svartz N. The treatment of 124 cases of ulcerative colitis with salazopyrin and attempts of desensibilisation in cases of hypersensitiveness to sulfa. Acta Med Scand 1948: 206: 465–72
- Truelove SC, Witts LJ. Cortisone in ulcerative colitis: final report on a therapeutic trial. BMJ 1955: 2: 1041–8
- Dissanayake AS, Truelove SC. A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (salazopyrin). Gut 1973: 14(12): 923–6
- Azad Khan AK, Piris J, Truelove SC. An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet 1977: 2(8044): 892–5
- Peppercorn MA. Sulfasalazine: pharmacology, clinical use, toxicity, and related new drug development. Ann Intern Med 1984: 101 (3): 377–86
- Sutherland LR, Martin F, Greer S, et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 1987: 92(6): 1894–8
- Campieri M, Lanfranchi GA, Bazzocchi G, et al. Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas. Lancet 1981: 2(8241): 270–1
- Campieri M, Lanfranchi GA, Brignola C, et al. 5-aminosalicylic acid as rectal enema in ulcerative colitis patients unable to take sulphasalazine. (Letter) Lancet 1984: 1 (8373): 403
- Campieri M, Lanfranchi GA, Bertoni F, et al. A double-blind clinical trial to compare the effects of 4-aminosalicylic acid to 5-aminosalicylic acid in topical treatment of ulcerative colitis. Digestion 1984: 29(4): 204–8
- Ginsberg AL, Beck LS, McIntosh TM, et al. Treatment of left-sided ulcerative colitis with 4-aminosalicylic acid enemas: a double-blind, place-bo-controlled trial. Ann Intern Med 1988: 108(2): 195–9
- Robert A. Gastric cytoprotection by sodium salicylate. Prostaglandins 1981: 21 (Suppl): 139–46
- Hawkey CJ, Kemp RT, Walt RP, et al. Evidence that adaptive cytoprotection in rats is not mediated by prostaglandins. Gastroenterology 1988: 94(4): 948–54
- Cho CH, Ogle CW, Sevilla EL. The protective effects of sulphasalazine against ethanol-induced gastric damage in rats. Br J Pharmacol 1987: 92(1): 31–7
- Nielsen OH, Ahnfelt-Renne I. 4-Aminosalicylic acid, in contrast to 5-aminosalicylic acid, has no effect on arachidonic acid metabolism in human neutrophils, or on the free radical l, 1 -diphenyl-2-picrylhydrazyl. Pharmacol Toxicol 1988: 62(4): 223–6
- Ginsberg AL, Steinberg WM, Nochomovitz LE. Deterioration of left-sided ulcerative colitis after withdrawal of sulfasalazine. (Abstr) Gastroenterology 1985: 88: A1395
- Goodman MW, Eberle DE, Kuchler LA, et al. Microscopic activity predicts relapse in patients with distal ulcerative colitis on 4-aminosalicylic acid enemas. Gastroenterology (Abstr) 1988: 94: A151
- Biddle WL, Greenberger NJ, Swan JT, et al. 5-Aminosalicylic acid enemas: effective agent in maintaining remission in left-sided ulcerative colitis. Gastroenterology 1988: 94(4): 1075–9 [erratum, Gastroenterology 1989: 96(6): 1630]
- Guarino J, Chatzinoff M, Berk T, et al. 5- Aminosalicylic acid enemas in refractory distal ulcerative colitis: long-term results. Am J Gastroenterol 1987: 82(8): 732–7
- Robinson MG. New oral salicylates in the therapy of chronic idiopathic inflammatory bowel disease. Gastroenterol Clin North Am 1989: 18(1): 43–50